Suita, Japan

Aki Kanehira

This inventor holds 1 USPTO granted patent. Top assignee: Dainippon Pharmaceutical Company, Limited. Active years: 1998.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Aki Kanehira. Retrieved from https://idiyas.com/inventor/aki-kanehira

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 7.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 1998

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Aki Kanehira: Innovator in Cyclic Amine Derivatives

Introduction

Aki Kanehira is a notable inventor based in Suita, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of cyclic amine derivatives. His work has led to the filing of a patent that showcases his innovative approach to chemical compounds.

Latest Patents

Aki Kanehira holds a patent for "1-ω-(3,4-dihydro-2-naphthalenyl)alkyl!-cyclic amine derivatives." This patent reflects his expertise in creating novel chemical structures that may have important applications in medicine.

Career Highlights

Kanehira is associated with Dainippon Pharmaceutical Company, Limited, where he has been instrumental in advancing research and development initiatives. His work at the company has positioned him as a key player in the pharmaceutical industry.

Collaborations

Throughout his career, Aki Kanehira has collaborated with talented individuals such as Naoki Kai and Toshiya Morie. These partnerships have fostered a creative environment that encourages innovation and the sharing of ideas.

Conclusion

Aki Kanehira's contributions to the field of cyclic amine derivatives highlight his role as an influential inventor in the pharmaceutical industry. His patent and collaborations demonstrate his commitment to advancing medical science through innovative research.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…